Is serum Interleukin-17 associated with early atherosclerosis in obese patients?

Journal of Translational Medicine

Volumn 12, Issue 1, 2014, Pages

  Tarantino, Giovanni ^a,b   Costantini, Susan ^b   Finelli, Carmine ^c   Capone, Francesca ^b   Guerriero, Eliana ^b   La Sala, Nicolina ^c   Gioia, Saverio ^c   Castello, Giuseppe ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c Stella Maris Mediterraneum Foundation   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; OBESITY; OUTCOME ASSESSMENT; PREDICTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; BLOOD; COMPLICATION; NONALCOHOLIC FATTY LIVER;

ADULT; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; INTERLEUKIN-17; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84906730677     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-014-0214-1     Document Type: Article

References (44)

1. Fathi R, Marwick TH. Noninvasive tests of vascular function and structure: why and how to perform them. Am Heart J 2001, 141:694-703. 10.1067/mhj.2001.114972, 11320355.
2. Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol 2007, 22:293-303. 10.1111/j.1440-1746.2007.04824.x, 17295757.
3. Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A, Erbel R, Blankstein R, Feldman T, Al-Mallah MH, Santos RD, Budoff MJ, Nasir K. A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?. Atherosclerosis 2013, 230:258-267. 10.1016/j.atherosclerosis.2013.07.052, 24075754.
4. Novelli EL, Souza GA, Ebaid GM, Rocha KK, Seiva FR, Mani F, Campos KE, Sforcin JM. Energy expenditure and oxygen consumption as novel biomarkers of obesity-induced cardiac disease in rats. Obesity (Silver Spring) 2010, 18:1754-1761. 10.1038/oby.2009.470.
5. Pillen S, Arts IMP, Zwarts MJ. Muscle ultrasound in neuromuscular disorder. Muscle Nerve 2008, 37:679-693. 10.1002/mus.21015, 18506712.
6. Therkelsen KE, Pedley A, Speliotes EK, Massaro JM, Murabito J, Hoffmann U, Fox CS. Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2013, 33:863-870. 10.1161/ATVBAHA.112.301009, 23349188.
7. Frostegard J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (th1) and macrophage-stimulating cytokines. Atherosclerosis 1999, 145:33-43. 10.1016/S0021-9150(99)00011-8, 10428293.
8. Roselaar SE, Kakkanathu PX, Daugherty A. Lymphocyte populations in atherosclerotic lesions of apoe -/-and ldl receptor -/-mice. Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 1996, 16:1013-1018. 10.1161/01.ATV.16.8.1013, 8696940.
9. Xu JM, Shi GP. Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocr Rev 2012, 33:71-108. 10.1210/er.2011-0013, 22240242.
10. Tarantino G, Costantini S, Finelli C, Capone F, Guerriro E, La Sala N, Gioia S, Castello G: Carotid intima-media thickness is predicted by combined eotaxin levels and the severity of hepatic steatosis at ultrasonography in obese patient with NAFLD.PLoS One, in press..
11. Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of IL-17 family members. Immunity 2011, 34:149-162. 10.1016/j.immuni.2011.02.012, 21349428.
12. Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, Ley K, Galkina E. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010, 121:1746-1755. 10.1161/CIRCULATIONAHA.109.924886, 20368519.
13. Gao Q, Jiang Y, Ma T, Zhu F, Gao F, Zhang P, Guo C, Wang Q, Wang X, Ma C, Zhang Y, Chen W, Zhang L. A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol 2010, 185:5820-5827. 10.4049/jimmunol.1000116, 20952673.
14. Danzaki K, Matsui Y, Ikesue M, Ohta D, Ito K, Kanayama M, Kurotaki D, Morimoto J, Iwakura Y, Yagita H, Tsutsui H, Uede T. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2012, 32:273-280. 10.1161/ATVBAHA.111.229997, 22116098.
15. Simon T, Taleb S, Danchin N, Laurans L, Rousseau B, Cattan S, Montely JM, Dubourg O, Tedgui A, Kotti S, Mallat Z. Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction. Eur Heart J 2013, 34:570-577. 10.1093/eurheartj/ehs263, 22956509.
16. Wang YH, Voo KS, Liu B, Chen CY, Uygungil B, Spoede W, Bernstein JA, Huston DP, Liu YJ. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med 2010, 207:2479-2491. 10.1084/jem.20101376, 20921287.
17. Rothenbacher D, Mu¨ller-Scholze S, Herder C, Koenig W, Kolb H. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol 2006, 26:194-199. 10.1161/01.ATV.0000191633.52585.14, 16239601.
18. Montalcini T, Gazzaruso C, Ferro Y, Migliaccio V, Rotundo S, Castagna A, Pujia A. Metabolic fuel utilization and subclinical atherosclerosis in overweight/obese subjects. Endocrine 2013, 44:380-385. 10.1007/s12020-012-9845-2, 23188694.
19. Webb M, Yeshua H, Zelber-Sagi S, Santo E, Brazowski E, Halpern Z, Oren R. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am J Roentgenol 2009, 192:909-914. 10.2214/AJR.07.4016, 19304694.
20. Pillen S, van Alfen N. Skeletal muscle ultrasound. Neurol Res 2011, 33:1016-1024. 10.1179/1743132811Y.0000000010, 22196753.
21. Heckmatt JZ, Leeman S, Dubowitz V. Ultrasound imaging in the diagnosis of muscle disease. J Pediatr 1982, 101:656-660. 10.1016/S0022-3476(82)80286-2, 7131136.
22. Tarantino G, Finelli C, Colao A, Capone D, Tarantino M, Grimaldi E, Chianese D, Gioia S, Pasanisi F, Contaldo F, Scopacasa F, Savastano S. Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?. J Transl Med 2012, 10:50. 10.1186/1479-5876-10-50, 22424154.
23. Tarantino G, Marra M, Contaldo F, Pasanisi F. Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease. Clin Invest Med 2008, 31:E24-E29. 18312746.
24. Schutz Y, Kyle UU, Pichard C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98 y. Int J Obes Relat Metab Disord 2002, 26:953-960. 10.1038/sj.ijo.0801856, 12080449.
25. Arellano-Garcia ME, Hu S, Wang J, Henson B, Zhou H, Chia D, Wong DT. Multiplexed immunobead-based assay for detection of oral cancer protein biomarkers in saliva. Oral Dis 2008, 14:705-712. 10.1111/j.1601-0825.2008.01488.x, 19193200.
26. Le´de´e N, Munaut C, Se´razin V, Perrier d'Hauterive S, Lombardelli L, Logiodice F, Wainer R, Gridelet V, Chaouat G, Frankenne F, Foidart JM, Piccinni MP. Performance evaluation of microbead and ELISA assays for follicular G-CSF: a non-invasive biomarker of oocyte developmental competence for embryo implantation. J Reprod Immunol 2010, 86:126-132. 10.1016/j.jri.2010.05.003, 20594599.
27. Kawaguchi M, Kokubu F, Fujita J, Huang SK, Hizawa N. Role of interleukin-17F in asthma. Inflamm Allergy Drug Targets 2009, 8:383-389. 10.2174/1871528110908050383, 20025586.
28. Makki K, Froguel P, Wolowczuk I. Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm 2013, 2013:139239. 10.1155/2013/139239, 24455420.
29. Ghaffar O, Hamid Q, Renzi PM, Allakhverdi Z, Molet S, Hogg JC, Shore SA, Luster AD, Lamkhioued B. Constitutive and cytokine-stimulated expression of eotaxin by human airway smooth muscle cells. Am J Respir Crit Care Med 1999, 159:1933-1942. 10351942.
30. Brunetti ND, Salvemini G, Cuculo A, Ruggiero A, De Gennaro L, Gaglione A, Di Biase M. Coronary artery ectasia is related to coronary slow flow and inflammatory activation. Atherosclerosis 2014, 233:636-640. 10.1016/j.atherosclerosis.2014.01.018, 24553454.
31. Sumarac-Dumanovic M, Stevanovic D, Ljubic A, Jorga J, Simic M, Stamenkovic-Pejkovic D, Starcevic V, Trajkovic V, Micic D. Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes (Lond) 2009, 33:151-156. 10.1038/ijo.2008.216.
32. Ahmed M, Gaffen SL. IL-17 in obesity and adipogenesis. Cytokine Growth Factor Rev 2010, 21:449-453. 10.1016/j.cytogfr.2010.10.005, 21084215.
33. Zuniga LA, Shen WJ, Joyce-Shaikh B, Pyatnova EA, Richards AG, Thom C, Andrade SM, Cua DJ, Kraemer FB, Butcher EC. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol 2010, 185:6947-6959. 10.4049/jimmunol.1001269, 21037091.
34. Zhu F, Wang Q, Guo C, Wang X, Cao X, Shi Y, Gao F, Ma C, Zhang L. IL-17 induces apoptosis of vascular endothelial cells: potential mechanism for human acute coronary syndrome. Clin Immunol 2011, 141:152-160. 10.1016/j.clim.2011.07.003, 21872532.
35. Chhabra R, O'Keefe JH, Patil H, O'Keefe E, Thompson RC, Ansari S, Kennedy KF, Lee LW, Helzberg JH. Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals. Mayo Clin Proc 2013, 88:1259-1265. 10.1016/j.mayocp.2013.06.025, 24138963.
36. Tarantino G, Caputi A. JNKs, insulin resistance and inflammation: a possible link between NAFLD and coronary artery disease. World J Gastroenterol 2011, 17:3785-3794. 10.3748/wjg.v17.i33.3785, 21987620.
37. Rauramaa R, Va¨isa¨nen S, Mercuri M, Rankinen T, Penttila I, Bond MG. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men. Eur Heart J 1994, 15:1020-1027. 7988592.
38. Riesenberg K, Levy R, Katz A, Galkop S, Schlaeffer F. Neutrophil superoxide release and interleukin 8 in acute myocardial infarction: distinction between complicated and uncomplicated states. Eur J Clin Invest 1997, 27:398-404. 10.1046/j.1365-2362.1997.1270667.x, 9179547.
39. Zhou RH, Shi Q, Gao HQ, Shen BJ. Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population. J Atheroscler Thromb 2001, 8:30-32. 10.5551/jat1994.8.30, 11686313.
40. Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw KT. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004, 24:1503-1508. 10.1161/01.ATV.0000134294.54422.2e, 15178568.
41. Lefer AM, Johnson G, Ma XL, Tsao PS, Thomas GR. Cardioprotective and endothelial protective effects of [Ala-IL8]77 in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol 1991, 103:1153-1159. 10.1111/j.1476-5381.1991.tb12316.x, 1652342.
42. Claridge MW, Bate GR, Hoskins PR, Adam DJ, Bradbury AW, Wilmink AB. Measurement of arterial stiffness in subjects with vascular disease: Are vessel wall changes more sensitive than increase in intima-media thickness?. Atherosclerosis 2009, 205:477-480. 10.1016/j.atherosclerosis.2008.12.030, 19200543.
43. Yu XH, Jiang N, Zheng XL, Cayabyab FS, Tang ZB, Tang CK. Interleukin-17A in lipid metabolism and atherosclerosis. Clin Chim Acta 2014, 431C:33-39. 10.1016/j.cca.2014.01.012.
44. Savva SC, Lamnisos D, Kafatos AG, Savva SC, Lamnisos D, Kafatos AG. Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis. Diabetes Metab Syndr Obes 2013, 6:403-419. 10.2147/DMSO.S34220, 24179379.